Peter Dasak's DEFUSE proposal at WIV
https://s3.do entcloud.org/do en...e-proposal.pdf
We’ve gone over the geographic and genomic evidence that makes SARS-CoV-2 highly unusual among other SARS coronaviruses. SARS-CoV-2 emerged in Wuhan in 2019 far from the hotspots of wildlife coronavirus diversity, right next door to world leading labs studying wildlife coronaviruses, and it emerged with a human-specific furin cleavage site and the restriction map of an infectious clone.
Less than 1.5 years earlier, researchers at the Wuhan Ins ute of Virology and elsewhere proposed to insert a human-specific furin cleavage site in a SARS coronavirus in Wuhan.
Read those last two paragraphs again.
The DEFUSE proposal is where researchers laid out their intentions to make a virus shockingly similar to SARS-CoV-2 in all of the ways in which SARS-CoV-2 is glaringly different from wildlife SARS coronaviruses.
The DEFUSE proposal was a grant proposal written by Peter Daszak at EcoHealth Alliance in NYC (EHA), Zheng-Li Shi at the Wuhan Ins ute of Virology (WIV), Ralph Baric at the University of North Carolina (UNC), Linfa Wang at Duke-NUS Singapore, and others. The proposal was submitted to DARPA’s PREEMPT call, a grant call looking for innovative ideas to preempt pathogen spillover before it occurs.
The DEFUSE proposal contained many specific aims: catching bats, sending samples from bats to labs, looking for viruses in the samples, studying and modifying the viruses in labs, developing raccoon poxvirus vaccines to boost immunity & protect bats against the viruses, testing the viruses + immune-boosting in bats, forecasting where spillover is most likely to occur, and deploying vaccines in wild bats to preempt spillover.
If you look on page 11 of the main do ent, page 13 of the online PDF above, under the section labelled “S2 proteolytic cleavage and glycosylation sites”, you can find the most important passage in this do ent.
The researchers propose to scan SARS-CoV genomes for potential furin cleavage sites and, where none exist, they propose to insert the appropriate cleavage sites. Specifically, they say:
”… we will introduce appropriate human-specific cleavage sites and evaluate growth potential in Vero and HAE cells”
In other words, a major aim of the DEFUSE proposal was to study furin cleavage sites, features never before do ented in SARS CoVs. They would look for furin cleavage sites that might exist and, where none existed, they will introduce human-specific cleavage sites to create a virus not found in nature but hypothesized- for good mechanistic reasons based on our knowledge of furin cleavage sites - to have higher transmissibility in people and, consequently, a higher risk of causing a pandemic like the COVID-19 pandemic. Where none existed, researchers proposed to insert human-specific furin cleavage sites in viruses, and study whether or not their poxvirus vaccine protects bats from these unnatural coronaviruses they designed. Studies of the infectivity of high-risk strains in bats, and whether or not the immune boosting methods at Duke-NUS protected bats from high-risk strains, was proposed to take place at the Wuhan Ins ute of Virology.
The DEFUSE grant was not funded, but that doesn’t mean the research didn’t continue. Scientists are often like actors: the show must go on. EcoHealth Alliance had many sources of funding, and the proposed research inserting a human-specific FCS in a bat SARS-CoV is relatively inexpensive. In fact, three PIs of DEFUSE - Peter Daszak, Lin-Fa Wang, and Zheng-Li Shi, had created a chimeric bat coronavirus in 2016 without the involvement of UNC. Peter Daszak had a grant at NIAID - Understanding the Risk of Bat Coronavirus Emergence - that funded a collaboration between EcoHealth Alliance and Chinese researchers, including Zheng-Li Shi at the Wuhan Ins ute of Virology, to study bat coronaviruses in China (Ralph Baric was missing from both the 2016 paper and, apparently, the NIAID grant). The NIAID grant was listed in the acknowledgements for their construction of a recombinant bat SARS CoV in the 2016 paper. Researchers in China also had access to alternative lines of funding. The researchers had ample means to follow through with their intentions spelled out in DEFUSE, especially relatively inexpensive work but exciting work such as inserting human-specific furin cleavage sites in SARS CoV infectious clones.
In 2018, researchers indisputably proposed to insert human-specific furin cleavage sites in bat SARS-CoVs in a collaboration involving the Wuhan Ins ute of Virology. Their prior work creating recombinant CoVs used a particular method to construct infectious clones of viruses using reverse genetics systems.
In late 2019, SARS-CoV-2 emerged with a human-specific furin cleavage site in what otherwise looked like a bat SARS-CoV right outside the Wuhan Ins ute of Virology. This virus is anomalous among wild coronaviruses in just how consistent it is with reverse genetic systems, all the way down to silent mutations significantly concentrated in restriction sites.
Every single anomalous feature of SARS-CoV-2 that leads us to suspect a lab origin, features not seen in over 1,000 years of evolutionary time, was spelled out in a grant just over 1 year prior to the emergence of the virus. That grant did not propose to do its work in Atlanta nor Athens nor Cape Town nor Milan nor Buenos Aires. It proposed to do this work in Wuhan.
The virus with this lab-looking genome was not found in animals in the wet market. It was equally likely to be found underneath animal traders as vegetable traders. It did not cause a geographically widespread outbreak consistent with an animal trade outbreak. Simply put, it did not look zoonotic in ways that are easily explained by a lab origin, and it has a genome that looks exactly like a research product from a proposal to make recombinant bat coronaviruses in Wuhan.
https://alexwasburne.substack.com/p/...origin-of-sars